Company / Operating Margin
Outlook Therapeutics, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-5072.6%
FY2025
5-year range
-5072.6% / -445.6%
FY2021-FY2025
Trend
-1038.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -1038% YoY in FY2025, a notable deviation from the 5-year average annual change of -207%.
Based on SEC 10-K filings.
-5072.6% in FY2025 with a 5-year CAGR of -4627.0%.
Declined from -960.1% to -5072.6% over the past 6 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -4627.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 1038.4% year-over-year.
- Peak operating margin was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -5072.6% | -1038.4% |
| FY2020 | -445.6% | +53.6% |
| FY2019 | -960.1% | -2.0% |
| FY2018 | -941.4% | +45.4% |
| FY2017 | -1723.3% | -93.2% |
| FY2016 | -892.1% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026